Pelthos Therapeutics (PTHS) Research & Development (2023 - 2026)
Pelthos Therapeutics (PTHS) reported Research & Development of $600,000 for Q2 2026, up 16.5% from $515,000 a year earlier and up 222.6% from the prior quarter.
Powered by 
Analysis
Pelthos Therapeutics (PTHS) Research & Development (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Pelthos Therapeutics' Research & Development came in at $1.31 million, down 7.4% year-over-year; for FY2025, it came in at $1.23 million, up 4.2% from FY2024.
- Research & Development has a three-year compound annual growth rate of 46.4% (FY2022 to FY2025).
- By year, Research & Development came in at $1.18 million in FY2024 (-54.3%), $2.58 million in FY2023 (+558.5%) and $391,730 in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Research & Development since Q4 2023.
- Year over year, Research & Development gained in three of the last seven quarters, with growth averaging 82.5%.
- The high point for year-over-year Research & Development in five years was Q3 2024 (growth of 744.7%); the low point was Q4 2024 (a decline of 87.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $186,000 (Q1 2026), $374,000 (Q4 2025) and $145,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.69 Bn | 1,103.27 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 616.29 Bn | 534.82 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 500.86 Bn | 473.97 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.77 Bn | 321.15 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.69 Bn | 261.68 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.39 Bn | 235.08 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 235.52 Bn | 190.92 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 190.49 Bn | 164.69 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 169.46 Bn | 116.11 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Pelthos Therapeutics | 71.67 Mn | -16.72 Mn | 11.99 Mn | 600,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 600,000.00 |
| Mar 31, 2026 | 186,000.00 |
| Dec 31, 2025 | 374,000.00 |
| Sep 30, 2025 | 145,000.00 |
| Jun 30, 2025 | 515,000.00 |
| Mar 31, 2025 | 194,000.00 |
| Dec 31, 2024 | 285,000.00 |
| Sep 30, 2024 | 415,000.00 |
| Jun 30, 2024 | 12,955.00 |
| Mar 31, 2024 | 466,606.00 |
| Dec 31, 2023 | 2.29 Mn |
| Sep 30, 2023 | 49,132.00 |
| Jun 30, 2023 | 49,955.00 |
| Mar 31, 2023 | 186,117.00 |
API Access
Pelthos Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PTHS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PTHS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PTHS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();